Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - final report: Difference between revisions

From GxPlex

Jump to: navigation, search
← Older edit
gxplex>GxPlexBot
Import from GxPlex Excel
m 1 revision imported
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
{{#set:
{{ReferenceData
|HasDocument=Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995
|has_document=Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995
|RefScope=HM
|module=6
|RefDocPart=Glossary - final report
|unit=6.4.2
|RefLanguage=EN
|scope=HM
|RefTags=TAG-00050-Cli-ber ++ TAG-00244-Def-ini ++ TAG-00338-Met-odi ++ TAG-00056-Bio-tik
|doc_part=Glossary - final report
|RefModule=6
|language=EN
|RefUnit=6.4.2
|entry_by=Florian Adragna
|contributors=
|tags=TAG-00050-Cli-ber ++ TAG-00244-Def-ini ++ TAG-00338-Met-odi ++ TAG-00056-Bio-tik
|tags_display=[[Glossary:TAG-00050-Cli-ber|Clinical study report]], [[Glossary:TAG-00244-Def-ini|Definition]], [[Glossary:TAG-00338-Met-odi|Methodology]], [[Glossary:TAG-00056-Bio-tik|Biostatistics]]
|comment=Definition of final report
|content=final report
A comprehensive description of the trial after its completion including a description of experimental methods (including statistical methods) and materials, a presentation and evaluation of the results, statistical analyses and a critical, ethical, statistical and clinical appraisal.
}}
}}
{{:Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995}}
{| class="wikitable gplx-infobox"
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Module
| Module 6 — Unit 6.4.2
|-
! Scope
| HM
|-
! Document part
| Glossary - final report
|-
! Language
| EN
|-
! Original entry by
| Florian Adragna
|-
! Contributors
|
|-
! Tags
| [[Glossary:TAG-00050-Cli-ber|Clinical study report]], [[Glossary:TAG-00244-Def-ini|Definition]], [[Glossary:TAG-00338-Met-odi|Methodology]], [[Glossary:TAG-00056-Bio-tik|Biostatistics]]
|-
! Comment
| Definition of final report
|}
== Content ==
final report
A comprehensive description of the trial after its completion including a description of experimental methods (including statistical methods) and materials, a presentation and evaluation of the results, statistical analyses and a critical, ethical, statistical and clinical appraisal.

Latest revision as of 13:50, 16 July 2026



Document information
Reference WHO WHO - Guidelines for GCP for trials on

pharmaceutical products* 1995

Validity area WHO
Scope(s) HM
Document name WHO - Guidelines for GCP for trials on

pharmaceutical products*

Version / Revision 1995
Status Current
Document type International guideline
Language(s) EN
Description World Health Organization

WHO Technical Report Series, No. 850, 1995, Annex 3 Guidelines for good clinical practice (GCP) for trials on pharmaceutical products*

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 6 — Unit 6.4.2
Scope HM
Document part Glossary - final report
Language EN
Original entry by Florian Adragna
Contributors
Tags Clinical study report, Definition, Methodology, Biostatistics

Content

final report A comprehensive description of the trial after its completion including a description of experimental methods (including statistical methods) and materials, a presentation and evaluation of the results, statistical analyses and a critical, ethical, statistical and clinical appraisal.

Retrieved from "https://gxplex.org/index.php?title=Reference:WHO_WHO_-_Guidelines_for_GCP_for_trials_on_pharmaceutical_products*_1995_Glossary_-_final_report&oldid=19513"